Benchmark analyst Matthew Harrigan raised the firm’s price target on Lionsgate Studios (LION) to $15 from $12 and keeps a Buy rating on the shares following this weekend’s better-than-anticipated results from the opening weekend for the “Michael” biopic. There could be further upside from financial outperformance commencing in current fiscal 2027 “given high appeal from very familiar IP in the pipeline, especially The Resurrection of the Christ,” the analyst added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LION:
- Lionsgate Studios downgraded to Neutral from Buy at Citi
- Lionsgate Studios price target raised to $14 from $12 at Baird
- Lionsgate Extends CEO Contract with Performance-Based Equity Plan
- The AI Backlash, or, The Hollywood Revolution That Fizzled
- Lionsgate Studios price target raised to $11 from $9 at Citi